pirfenidone has been researched along with Glomerulosclerosis, Focal Segmental in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Branton, MH; Cho, ME; Kopp, JB; Penzak, SR; Smith, DC | 1 |
1 other study(ies) available for pirfenidone and Glomerulosclerosis, Focal Segmental
| Article | Year |
|---|---|
Pirfenidone slows renal function decline in patients with focal segmental glomerulosclerosis.
Topics: Adult; Aged; Female; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Humans; Kidney; Male; Middle Aged; Pilot Projects; Prospective Studies; Pyridones | 2007 |